H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.24 HKD 0.7% Market Closed
Market Cap: 102.3B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Hansoh Pharmaceutical Group Company Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hansoh Pharmaceutical Group Company Ltd
Income from Continuing Operations Peer Comparison

Comparables:
600196
600436
600276
000538
S
688506

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Income from Continuing Operations
ÂĄ2.4B
CAGR 3-Years
-21%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income from Continuing Operations
ÂĄ3B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
ÂĄ4.5B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
-ÂĄ780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hansoh Pharmaceutical Group Company Ltd's Income from Continuing Operations?
Income from Continuing Operations
3.3B CNY

Based on the financial report for Dec 31, 2023, Hansoh Pharmaceutical Group Company Ltd's Income from Continuing Operations amounts to 3.3B CNY.

What is Hansoh Pharmaceutical Group Company Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
11%

Over the last year, the Income from Continuing Operations growth was 27%. The average annual Income from Continuing Operations growth rates for Hansoh Pharmaceutical Group Company Ltd have been 8% over the past three years , 11% over the past five years .

Back to Top